US2009093411A1PendingUtilityA1
Long-acting hormone and growth factor compositions and uses thereof
Est. expiryJan 31, 2022(expired)· nominal 20-yr term from priority
A61K 47/56A61K 47/64A61P 5/00
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides VEGF-FSH compounds having increased serum half-lives relative to either native VEGF or FSH, in which both VEGF and FSH are biologically active. This invention also provides related compositions and methods for increasing fertility, egg production and spermatogenesis in a subject, as well as methods for increasing vascularization in a tissue, particularly in ovarian tissue.
Claims
exact text as granted — not AI-modified1 . A composition of matter comprising (a) at least one subunit of a hormone or growth factor and (b) a half-life-increasing moiety, wherein the hormone or growth factor subunit and half-life-increasing moiety are covalently bound.
2 - 19 . (canceled)
20 . A composition of matter comprising (a) at least one subunit of a hormone or growth factor, (b) a half-life-increasing moiety, and (c) a moiety that specifically binds to cells of a predetermined tissue.
21 . A composition of matter comprising (a) at least one subunit of a hormone or growth factor, (b) a β-FSH subunit of a hormone or growth, (c) an α-FSH subunit and (d) a half-life-increasing moiety, wherein the hormone or growth factor, the β-FSH subunit, the α-FSH subunit and the half-life-increasing moiety are covalently bound.
22 - 66 . (canceled)Join the waitlist — get patent alerts
Track US2009093411A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.